Dubai, Emiratos Árabes Unidos
MX$ 93,578,515 - MX$ 187,157,030
Data Analytics and Business Intelligence Expert, Artificial General Intelligence and Crypto asset Anti-Money laundering. Decentralised finance. ACAMS Certified.
Blockchain, Crypto Assets, DeFi, Anti-Money Laundering, AI
Oncology therapeutics redefined Onconetix, Inc. (Nasdaq: ONCO) (formerly Blue Water Biotech, Inc. (BWV)) is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The Company currently has Entadfi®, an FDA approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix®, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. For more information, visit www.onconetix.com.
Innovating Healthcare and Life Sciences from Every Angle Throughout healthcare, providers, payers, and biopharma professionals are working hard to improve the system and deliver the best outcomes for patients and consumers. True change agents know it can’t be done alone. We strive to partner with you to reinforce your progress with our breakthrough technology and healthcare know-how. Together we’ll create an unshakeable system where you are empowered to do the work needed to transform healthcare.
Finanzas
Software
Tecnología
Agrícola y Agronegocios
Servicios Empresariales
Educación y Formación
Energía y Recursos Naturales
Ocio y Entretenimiento
Moda y Belleza
Alimentos y Bebidas
Hostelería, Restaurantes y Bares
Fabricación e Ingeniería
Medios
Medicina y Farmacéutica
Servicios Personales
Productos e Inventos
Inmobiliario
Comercio al Por Menor
Ventas y Marketing
Transporte
AIN facilita la creación de relaciones duraderas y rentables entre emprendedores e inversores, lo que redunda en negocios mejores y un futuro más brillante